Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 7 call positions ($86.3m notional), 3 put positions ($224.3m notional) – listed below, not included above.
Holdings, Q3 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $96.3m11.42% | — |
| GSK PLC GSK | $87.3m10.35% | — |
| HORIZON THERAPEUTICS PUB L HZNP | $78.6m9.32% | — |
| NATERA INC NTRA | $62.5m7.41% | — |
| UNITED THERAPEUTICS CORP DEL UTHR | $53.4m6.34% | — |
| DANAHER CORPORATION DHR | $42.0m4.98% | — |
| SANOFI SNY | $37.9m4.49% | — |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $32.8m3.89% | — |
| SYNDAX PHARMACEUTICALS INC SNDX | $29.1m3.45% | — |
| ENVISTA HOLDINGS CORPORATION NVST | $20.8m2.46% | — |
| ILLUMINA INC ILMN | $20.4m2.42% | — |
| COMMUNITY HEALTH SYS INC NEW CYH | $19.0m2.25% | — |
| CELLDEX THERAPEUTICS INC NEW CLDX | $17.6m2.09% | — |
| BIOGEN INC BIIB | $16.1m1.90% | — |
| ELEVANCE HEALTH INC ELV | $15.0m1.78% | — |
| CENTENE CORP DEL CNC | $14.9m1.77% | — |
| LANTHEUS HLDGS INC LNTH | $14.6m1.73% | — |
| AMARIN CORP PLC SPONS ADR NEW | $13.0m1.55% | — |
| ABIOMED INC ABMD | $13.0m1.54% | — |
| SERES THERAPEUTICS INC COM | $12.4m1.47% | — |
| HUMANA INC HUM | $11.9m1.42% | — |
| VIRIDIAN THERAPEUTICS INC VRDN | $9.8m1.16% | — |
| AMNEAL PHARMACEUTICALS INC AMRX | $9.5m1.12% | — |
| XENON PHARMACEUTICALS INC XENE | $9.4m1.11% | — |
| GUARDANT HEALTH INC GH | $9.2m1.09% | — |
| IONIS PHARMACEUTICALS INC IONS | $8.9m1.06% | — |
| SPDR SER TR XBI | $7.9m0.94% | — |
| LIQUIDIA CORPORATION LQDA | $7.6m0.90% | — |
| TARO PHARMACEUTICAL INDS LTD TARO | $6.7m0.79% | — |
| GOSSAMER BIO INC GOSS | $6.6m0.78% | — |
| PLIANT THERAPEUTICS INC PLRX | $6.1m0.73% | — |
| MERUS N V MRUS | $5.5m0.66% | — |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $4.1m0.48% | — |
| AFFIMED N V COM | $3.9m0.46% | — |
| AERIE PHARMACEUTICALS INC AERI | $3.9m0.46% | — |
| PUMA BIOTECHNOLOGY INC PBYI | $3.6m0.42% | — |
| VERA THERAPEUTICS INC VERA | $3.3m0.39% | — |
| FATE THERAPEUTICS INC FATE | $3.2m0.38% | — |
| POINT BIOPHARMA GLOBAL INC COM | $3.2m0.38% | — |
| AGILENT TECHNOLOGIES INC A | $2.6m0.31% | — |
| 908 DEVICES INC MASS | $2.2m0.26% | — |
| ICON PLC ICLR | $1.9m0.22% | — |
| INTUITIVE SURGICAL INC ISRG | $1.7m0.20% | — |
| XOMA ROYALTY CORPORATION XOMA | $1.6m0.19% | — |
| IQVIA HLDGS INC IQV | $1.5m0.18% | — |
| LABORATORY CORP AMER HLDGS COM NEW | $1.5m0.18% | — |
| AVANTOR INC AVTR | $1.5m0.17% | — |
| AADI BIOSCIENCE INC WHWK | $1.4m0.17% | — |
| REVVITY INC RVTY | $1.3m0.16% | — |
| ARGENX SE ARGX | $1.2m0.15% | — |
| MILESTONE PHARMACEUTICALS IN MIST | $1.2m0.14% | — |
| REPLIGEN CORP RGEN | $681.3k0.08% | — |
| HESKA CORP HSKA | $506.3k0.06% | — |
| AC IMMUNE SA ACIU | $393.7k0.05% | — |
| CABALETTA BIO INC CABA | $364.4k0.04% | — |
| SONIDA SENIOR LIVING INC SNDA | $191.5k0.02% | — |
| THIRD HARMONIC BIO INC COM | $189.7k0.02% | — |
| ELEDON PHARMACEUTICALS INC ELDN | $187.0k0.02% | — |
| GLYCOMIMETICS INC COM | $55.5k0.01% | — |
| BOLT BIOTHERAPEUTICS INC COM | $46.1k0.01% | — |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $208.9m781.7k shares | — |
| GSK PLC GSK · Call | $61.6m2.1m shares | — |
| BIOGEN INC BIIB · Put | $13.3m50.0k shares | — |
| BIOGEN INC BIIB · Call | $9.9m37.1k shares | — |
| SPDR SER TR XBI · Call | $7.1m90.0k shares | — |
| MERCK & CO INC MRK · Call | $4.2m48.7k shares | — |
| TEVA PHARMACEUTICAL INDS LTD Call | $2.2m272.9k shares | — |
| AMN HEALTHCARE SVCS INC AMN · Put | $2.0m19.0k shares | — |
| COMMUNITY HEALTH SYS INC NEW CYH · Call | $672.7k312.9k shares | — |
| MARAVAI LIFESCIENCES HLDGS I MRVI · Call | $612.7k24.0k shares | — |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |